跳至主要内容
临床试验/NCT04166760
NCT04166760已完成不适用

Metabolic Effects of Whey Compounds in Patients With Diabetes Mellitus Type 2.

University of Aarhus1 个研究点 分布在 1 个国家目标入组 16 人开始时间: 2020年1月6日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
16
试验地点
1
主要终点
Difference in iAUC for insulin between WHE and speWHE

研究概览

简要总结

The main objective of our study is to investigate the metabolic effects of a i) ordinary whey protein (WHE) and ii) a specific whey protein fraction (speWHE) when the interventions are ingested by patients with type 2 diabetes 30 minutes prior to an oral glucose tolerance test (OGTT). We will also investigate the glucose response when the patients ingest the interventions at home in their own environment 30 minutes before breakfast and dinner (2days) and also monitor glucose levels without interventions (2 days).

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Crossover
主要目的
Treatment
盲法
Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Age > 18 years
  • Type 2 diabetes (T2D) diagnosis
  • No medical treatment or metformin/sulfonylureas(SU) alone in the treatment of T2D
  • No daily use of protein drinks
  • Hba1c between 40 mmol/mol and 69 mmol/mol
  • 20 kg/m2 < BMI < 35 kg/m2
  • Screening blood test: 1200 pmol/l > C-peptid > 370 pmol/l

排除标准

  • Other diabetes medication than metformin/SU (e.g. insulin, GLP-1 analog, DPP-4 inhibitor, SGLT2-inhibitor)
  • Affected screening blood test assessed by the primary investigator(PI)/sponsor
  • Does not understand or speak danish
  • Milk allergy
  • PI finds the patient not fit (e.g. mental illness, too nervous or other)

结局指标

主要结局

Difference in iAUC for insulin between WHE and speWHE

时间窗: OGTT, 3 hours.

Difference in iAUC for insulin between WHE and speWHE

次要结局

  • Differences in iAUC and concentration differences for C-peptid(OGTT 3 hours)
  • Differences in iAUC and concentration differences for FFA(OGTT 3 hours)
  • Activity measurements(5 days)
  • continuous glucose measurement (CGM)(5 days)
  • Differences in iAUC and concentration differences for GIP(OGTT 3 hours)
  • Differences in iAUC and concentration differences for GLP-1(OGTT 3 hours)
  • Differences in iAUC and concentration differences for glucagon(OGTT 3 hours)
  • Differences in iAUC and concentration differences for glucose(OGTT 3 hours)

研究者

申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验